Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post
Last Updated: February 20, 2026, 10:50 am
Author: Getaka|Social: XLinkedIn
Stock Ticker - BSE: 530517 | NSE: RELAXO

Relaxo Footwears Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: February 20, 2026, 10:50 am

Market Cap 9,095 Cr.
Current Price 365
Intrinsic Value₹290.42
High / Low 531/351
Stock P/E54.2
Book Value 84.7
Dividend Yield0.83 %
ROCE11.2 %
ROE8.31 %
Face Value 1.00
PEG Ratio-9.64

Stock P/E, Current Price, and Intrinsic Value Over Time

View Share Price Target for Relaxo Footwears Ltd

Competitors

Stock Name ⇩Market Cap ⇩Current Price ⇩High / Low ⇩Stock P/E ⇩Book Value ⇩Dividend Yield ⇩ROCE ⇩ROE ⇩Face Value ⇩
Campus Activewear Ltd 8,111 Cr. 266 304/21057.6 26.00.37 %20.1 %17.2 % 5.00
AKI India Ltd 65.0 Cr. 6.11 16.2/5.5743.3 8.350.00 %4.54 %1.80 % 2.00
Relaxo Footwears Ltd 9,095 Cr. 365 531/35154.2 84.70.83 %11.2 %8.31 % 1.00
Liberty Shoes Ltd 425 Cr. 250 475/21036.4 1340.00 %9.99 %7.20 % 10.0
Khadim India Ltd 260 Cr. 142 311/13627.1 90.20.00 %9.34 %2.20 % 10.0
Industry Average5,690.20 Cr308.3545.6077.040.59%11.71%8.72%5.50

All Competitor Stocks of Relaxo Footwears Ltd

Quarterly Result

MetricDec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Sales 681765739715713747748679667695654629668
Expenses 609647631624626627649592584583555547599
Operating Profit 721181089287120998883112998169
OPM % 11%15%15%13%12%16%13%13%12%16%15%13%10%
Other Income 44711655778111211
Interest 4445555555555
Depreciation 32333537383839404039403939
Profit before tax 41857660518260504575664936
Tax % 26%26%26%27%24%25%26%26%26%25%26%26%26%
Net Profit 30635644396144373356493627
EPS in Rs 1.212.542.261.781.552.471.781.481.332.261.961.451.07

Last Updated: February 4, 2026, 10:16 am

Below is a detailed analysis of the quarterly data for Relaxo Footwears Ltd based on the most recent figures (Dec 2025) and their trends compared to the previous period:

  • For Sales, as of Dec 2025, the value is 668.00 Cr.. The value appears strong and on an upward trend. It has increased from 629.00 Cr. (Sep 2025) to 668.00 Cr., marking an increase of 39.00 Cr..
  • For Expenses, as of Dec 2025, the value is 599.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 547.00 Cr. (Sep 2025) to 599.00 Cr., marking an increase of 52.00 Cr..
  • For Operating Profit, as of Dec 2025, the value is 69.00 Cr.. The value appears to be declining and may need further review. It has decreased from 81.00 Cr. (Sep 2025) to 69.00 Cr., marking a decrease of 12.00 Cr..
  • For OPM %, as of Dec 2025, the value is 10.00%. The value appears to be declining and may need further review. It has decreased from 13.00% (Sep 2025) to 10.00%, marking a decrease of 3.00%.
  • For Other Income, as of Dec 2025, the value is 11.00 Cr.. The value appears to be declining and may need further review. It has decreased from 12.00 Cr. (Sep 2025) to 11.00 Cr., marking a decrease of 1.00 Cr..
  • For Interest, as of Dec 2025, the value is 5.00 Cr.. The value remains steady. There is no change compared to the previous period (Sep 2025) which recorded 5.00 Cr..
  • For Depreciation, as of Dec 2025, the value is 39.00 Cr.. The value remains steady. There is no change compared to the previous period (Sep 2025) which recorded 39.00 Cr..
  • For Profit before tax, as of Dec 2025, the value is 36.00 Cr.. The value appears to be declining and may need further review. It has decreased from 49.00 Cr. (Sep 2025) to 36.00 Cr., marking a decrease of 13.00 Cr..
  • For Tax %, as of Dec 2025, the value is 26.00%. The value remains steady. There is no change compared to the previous period (Sep 2025) which recorded 26.00%.
  • For Net Profit, as of Dec 2025, the value is 27.00 Cr.. The value appears to be declining and may need further review. It has decreased from 36.00 Cr. (Sep 2025) to 27.00 Cr., marking a decrease of 9.00 Cr..
  • For EPS in Rs, as of Dec 2025, the value is 1.07. The value appears to be declining and may need further review. It has decreased from 1.45 (Sep 2025) to 1.07, marking a decrease of 0.38.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: December 15, 2025, 4:44 am

MetricMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025TTM
Sales 1,1801,4411,6681,6311,9412,2922,4102,3592,6532,7832,9142,7902,645
Expenses 1,0321,2401,4271,4001,6391,9641,9981,8612,2352,4422,5052,4052,269
Operating Profit 148201241231302328413498418341409385376
OPM % 13%14%14%14%16%14%17%21%16%12%14%14%14%
Other Income 207144128222316292738
Interest 231823159919191722212421
Depreciation 314047515462109110114125147158159
Profit before tax 96143178178244268292391311210269230235
Tax % 31%28%32%33%34%35%22%25%25%26%26%26%
Net Profit 66103120120161175226292233154200170174
EPS in Rs 2.744.295.014.996.697.079.1111.749.356.218.056.847.00
Dividend Payout % 5%6%6%10%11%13%14%21%27%40%37%44%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year2014-20152015-20162016-20172017-20182018-20192019-20202020-20212021-20222022-20232023-20242024-2025
YoY Net Profit Growth (%)56.06%16.50%0.00%34.17%8.70%29.14%29.20%-20.21%-33.91%29.87%-15.00%
Change in YoY Net Profit Growth (%)0.00%-39.56%-16.50%34.17%-25.47%20.45%0.06%-49.41%-13.70%63.78%-44.87%

Relaxo Footwears Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.

Growth

Compounded Sales Growth
10 Years:7%
5 Years:3%
3 Years:2%
TTM:-8%
Compounded Profit Growth
10 Years:5%
5 Years:-6%
3 Years:-10%
TTM:-7%
Stock Price CAGR
10 Years:8%
5 Years:-5%
3 Years:-21%
1 Year:-39%
Return on Equity
10 Years:15%
5 Years:12%
3 Years:9%
Last Year:8%

Last Updated: September 5, 2025, 1:05 pm

Balance Sheet

Last Updated: December 4, 2025, 1:53 am

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Sep 2025
Equity Capital 661212121225252525252525
Reserves 2713624685947491,0931,2481,5481,7351,8301,9762,0732,085
Borrowings 198239236178153112139144174164205213215
Other Liabilities 182234281286335394430459448476508452545
Total Liabilities 6578419971,0701,2501,6111,8412,1762,3832,4952,7142,7622,870
Fixed Assets 3664725315415258489819389871,1501,3711,3441,336
CWIP 2422862138114611814989335475
Investments 0001100338194225108343422
Other Assets 2673674384665877528147821,0521,0301,2021,0211,037
Total Assets 6578419971,0701,2501,6111,8412,1762,3832,4952,7142,7622,870

Below is a detailed analysis of the balance sheet data for Relaxo Footwears Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:

  • For Equity Capital, as of Sep 2025, the value is 25.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 25.00 Cr..
  • For Reserves, as of Sep 2025, the value is 2,085.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,073.00 Cr. (Mar 2025) to 2,085.00 Cr., marking an increase of 12.00 Cr..
  • For Borrowings, as of Sep 2025, the value is 215.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 213.00 Cr. (Mar 2025) to 215.00 Cr., marking an increase of 2.00 Cr..
  • For Other Liabilities, as of Sep 2025, the value is 545.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 452.00 Cr. (Mar 2025) to 545.00 Cr., marking an increase of 93.00 Cr..
  • For Total Liabilities, as of Sep 2025, the value is 2,870.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 2,762.00 Cr. (Mar 2025) to 2,870.00 Cr., marking an increase of 108.00 Cr..
  • For Fixed Assets, as of Sep 2025, the value is 1,336.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,344.00 Cr. (Mar 2025) to 1,336.00 Cr., marking a decrease of 8.00 Cr..
  • For CWIP, as of Sep 2025, the value is 75.00 Cr.. The value appears strong and on an upward trend. It has increased from 54.00 Cr. (Mar 2025) to 75.00 Cr., marking an increase of 21.00 Cr..
  • For Investments, as of Sep 2025, the value is 422.00 Cr.. The value appears strong and on an upward trend. It has increased from 343.00 Cr. (Mar 2025) to 422.00 Cr., marking an increase of 79.00 Cr..
  • For Other Assets, as of Sep 2025, the value is 1,037.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,021.00 Cr. (Mar 2025) to 1,037.00 Cr., marking an increase of 16.00 Cr..
  • For Total Assets, as of Sep 2025, the value is 2,870.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,762.00 Cr. (Mar 2025) to 2,870.00 Cr., marking an increase of 108.00 Cr..

Notably, the Reserves (2,085.00 Cr.) exceed the Borrowings (215.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Reserves and Borrowings Chart

Cash Flow

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Cash from Operating Activity + 12510715918015412331951356400235406
Cash from Investing Activity + -70-130-130-89-108-56-116-45315-258-99-262
Cash from Financing Activity + -5121-31-89-46-68-203-56-70-138-106-162
Net Cash Flow 4-1-21-0-1141330-18

Free Cash Flow

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Free Cash Flow-50.00-38.005.0053.00149.00216.00274.00354.00244.00177.00204.00172.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Debtor Days 212124283335262834354541
Inventory Days 109163147146130130157154202154179177
Days Payable 396163637258658167697663
Cash Conversion Cycle 9112310811090107119101170121148155
Working Capital Days 51412192742574475596862
ROCE %26%30%30%26%30%26%24%26%18%12%14%11%

Financial Efficiency Indicators Chart

Share Holding Pattern

MonthDec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025
Promoters 71.02%71.25%71.27%71.27%71.27%71.27%71.27%71.27%71.27%71.27%71.27%71.27%
FIIs 2.99%2.82%2.87%3.24%3.39%3.32%3.36%3.41%3.27%3.07%2.85%3.04%
DIIs 7.64%7.96%8.34%8.53%8.86%9.33%9.54%9.98%10.54%10.55%9.95%9.88%
Public 18.34%17.98%17.51%16.96%16.47%16.07%15.82%15.34%14.92%15.13%15.93%15.82%
No. of Shareholders 3,61,9273,58,7003,43,2953,16,1352,91,4012,69,3882,52,9812,39,2452,37,1952,36,6772,39,5602,39,270

Shareholding Pattern Chart

No. of Shareholders

Relaxo Footwears Ltd: Intrinsic Value & Share Price Analysis - Shareholder trend analysis

Mutual Fund Holdings

Fund NameNo of SharesAUM (%)Amount Invested (Cr)Previous Number of SharesPrevious DatePercentage Change
SBI Small Cap Fund 11,800,000 1.32 477.191,800,0002025-12-08 01:55:51555.56%
SBI Large & Midcap Fund 4,049,449 0.44 163.761,550,0002025-12-08 01:55:51161.25%
SBI Equity Hybrid Fund 2,533,988 0.12 102.472,533,9882025-04-22 15:16:470%
SBI Childrens Fund - Investment Plan 1,812,156 1.45 73.28N/AN/AN/A
SBI Multicap Fund 1,621,704 0.28 65.581,621,7042025-04-22 15:56:540%
SBI Flexicap Fund 1,347,099 0.23 54.48N/AN/AN/A
ICICI Prudential Bharat Consumption Fund 307,585 0.38 12.44N/AN/AN/A
SBI Consumption Opportunities Fund 290,000 0.37 11.73N/AN/AN/A
ICICI Prudential FMCG Fund 221,692 0.47 8.97N/AN/AN/A
UTI Multi Asset Allocation Fund 60,298 0.04 2.44N/AN/AN/A

ROCE Trend

EPS Trend

Key Financial Ratios

MonthMar 25Mar 24Mar 23Mar 22Mar 21
FaceValue 1.001.001.001.001.00
Basic EPS (Rs.) 6.848.056.219.3611.74
Diluted EPS (Rs.) 6.848.056.219.3511.74
Cash EPS (Rs.) 13.2113.9811.2313.9116.17
Book Value[Excl.RevalReserv]/Share (Rs.) 84.2980.4074.5370.7263.30
Book Value[Incl.RevalReserv]/Share (Rs.) 84.2980.4074.5370.7263.30
Dividend / Share (Rs.) 3.003.002.502.502.50
Revenue From Operations / Share (Rs.) 112.08117.08111.80106.6094.97
PBDIT / Share (Rs.) 16.4317.4914.2417.6620.86
PBIT / Share (Rs.) 10.0711.579.2113.0916.43
PBT / Share (Rs.) 9.2410.828.4412.4815.75
Net Profit / Share (Rs.) 6.848.056.219.3511.74
PBDIT Margin (%) 14.6614.9412.7316.5621.96
PBIT Margin (%) 8.989.888.2312.2817.30
PBT Margin (%) 8.249.247.5411.7016.58
Net Profit Margin (%) 6.106.875.558.7612.35
Return on Networth / Equity (%) 8.1110.018.3213.2118.54
Return on Capital Employeed (%) 10.8313.1211.3216.9623.64
Return On Assets (%) 6.167.386.199.7613.40
Total Debt / Equity (X) 0.000.010.000.010.00
Asset Turnover Ratio (%) 1.021.121.141.161.17
Current Ratio (X) 2.742.402.542.572.40
Quick Ratio (X) 1.501.251.341.111.46
Inventory Turnover Ratio (X) 4.821.991.912.391.99
Dividend Payout Ratio (NP) (%) 43.8431.0440.2826.690.00
Dividend Payout Ratio (CP) (%) 22.7117.8822.2517.930.00
Earning Retention Ratio (%) 56.1668.9659.7273.310.00
Cash Earning Retention Ratio (%) 77.2982.1277.7582.070.00
Interest Coverage Ratio (X) 19.7923.3018.4228.6730.34
Interest Coverage Ratio (Post Tax) (X) 9.2411.739.0316.1818.07
Enterprise Value (Cr.) 10084.4420231.0821055.1126520.3321706.20
EV / Net Operating Revenue (X) 3.616.947.5710.009.20
EV / EBITDA (X) 24.6646.4659.4260.3541.88
MarketCap / Net Operating Revenue (X) 3.636.977.599.999.20
Retention Ratios (%) 56.1568.9559.7173.300.00
Price / BV (X) 4.8310.1511.3915.0613.81
Price / Net Operating Revenue (X) 3.636.977.599.999.20
EarningsYield 0.010.010.010.010.01

After reviewing the key financial ratios for Relaxo Footwears Ltd, here is a detailed analysis based on the latest available data and recent trends:

  • For FaceValue, as of Mar 25, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 1.00.
  • For Basic EPS (Rs.), as of Mar 25, the value is 6.84. This value is within the healthy range. It has decreased from 8.05 (Mar 24) to 6.84, marking a decrease of 1.21.
  • For Diluted EPS (Rs.), as of Mar 25, the value is 6.84. This value is within the healthy range. It has decreased from 8.05 (Mar 24) to 6.84, marking a decrease of 1.21.
  • For Cash EPS (Rs.), as of Mar 25, the value is 13.21. This value is within the healthy range. It has decreased from 13.98 (Mar 24) to 13.21, marking a decrease of 0.77.
  • For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 84.29. It has increased from 80.40 (Mar 24) to 84.29, marking an increase of 3.89.
  • For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 84.29. It has increased from 80.40 (Mar 24) to 84.29, marking an increase of 3.89.
  • For Dividend / Share (Rs.), as of Mar 25, the value is 3.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 3.00.
  • For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 112.08. It has decreased from 117.08 (Mar 24) to 112.08, marking a decrease of 5.00.
  • For PBDIT / Share (Rs.), as of Mar 25, the value is 16.43. This value is within the healthy range. It has decreased from 17.49 (Mar 24) to 16.43, marking a decrease of 1.06.
  • For PBIT / Share (Rs.), as of Mar 25, the value is 10.07. This value is within the healthy range. It has decreased from 11.57 (Mar 24) to 10.07, marking a decrease of 1.50.
  • For PBT / Share (Rs.), as of Mar 25, the value is 9.24. This value is within the healthy range. It has decreased from 10.82 (Mar 24) to 9.24, marking a decrease of 1.58.
  • For Net Profit / Share (Rs.), as of Mar 25, the value is 6.84. This value is within the healthy range. It has decreased from 8.05 (Mar 24) to 6.84, marking a decrease of 1.21.
  • For PBDIT Margin (%), as of Mar 25, the value is 14.66. This value is within the healthy range. It has decreased from 14.94 (Mar 24) to 14.66, marking a decrease of 0.28.
  • For PBIT Margin (%), as of Mar 25, the value is 8.98. This value is below the healthy minimum of 10. It has decreased from 9.88 (Mar 24) to 8.98, marking a decrease of 0.90.
  • For PBT Margin (%), as of Mar 25, the value is 8.24. This value is below the healthy minimum of 10. It has decreased from 9.24 (Mar 24) to 8.24, marking a decrease of 1.00.
  • For Net Profit Margin (%), as of Mar 25, the value is 6.10. This value is within the healthy range. It has decreased from 6.87 (Mar 24) to 6.10, marking a decrease of 0.77.
  • For Return on Networth / Equity (%), as of Mar 25, the value is 8.11. This value is below the healthy minimum of 15. It has decreased from 10.01 (Mar 24) to 8.11, marking a decrease of 1.90.
  • For Return on Capital Employeed (%), as of Mar 25, the value is 10.83. This value is within the healthy range. It has decreased from 13.12 (Mar 24) to 10.83, marking a decrease of 2.29.
  • For Return On Assets (%), as of Mar 25, the value is 6.16. This value is within the healthy range. It has decreased from 7.38 (Mar 24) to 6.16, marking a decrease of 1.22.
  • For Total Debt / Equity (X), as of Mar 25, the value is 0.00. This value is within the healthy range. It has decreased from 0.01 (Mar 24) to 0.00, marking a decrease of 0.01.
  • For Asset Turnover Ratio (%), as of Mar 25, the value is 1.02. It has decreased from 1.12 (Mar 24) to 1.02, marking a decrease of 0.10.
  • For Current Ratio (X), as of Mar 25, the value is 2.74. This value is within the healthy range. It has increased from 2.40 (Mar 24) to 2.74, marking an increase of 0.34.
  • For Quick Ratio (X), as of Mar 25, the value is 1.50. This value is within the healthy range. It has increased from 1.25 (Mar 24) to 1.50, marking an increase of 0.25.
  • For Inventory Turnover Ratio (X), as of Mar 25, the value is 4.82. This value is within the healthy range. It has increased from 1.99 (Mar 24) to 4.82, marking an increase of 2.83.
  • For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 43.84. This value is within the healthy range. It has increased from 31.04 (Mar 24) to 43.84, marking an increase of 12.80.
  • For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 22.71. This value is within the healthy range. It has increased from 17.88 (Mar 24) to 22.71, marking an increase of 4.83.
  • For Earning Retention Ratio (%), as of Mar 25, the value is 56.16. This value is within the healthy range. It has decreased from 68.96 (Mar 24) to 56.16, marking a decrease of 12.80.
  • For Cash Earning Retention Ratio (%), as of Mar 25, the value is 77.29. This value exceeds the healthy maximum of 70. It has decreased from 82.12 (Mar 24) to 77.29, marking a decrease of 4.83.
  • For Interest Coverage Ratio (X), as of Mar 25, the value is 19.79. This value is within the healthy range. It has decreased from 23.30 (Mar 24) to 19.79, marking a decrease of 3.51.
  • For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 9.24. This value is within the healthy range. It has decreased from 11.73 (Mar 24) to 9.24, marking a decrease of 2.49.
  • For Enterprise Value (Cr.), as of Mar 25, the value is 10,084.44. It has decreased from 20,231.08 (Mar 24) to 10,084.44, marking a decrease of 10,146.64.
  • For EV / Net Operating Revenue (X), as of Mar 25, the value is 3.61. This value exceeds the healthy maximum of 3. It has decreased from 6.94 (Mar 24) to 3.61, marking a decrease of 3.33.
  • For EV / EBITDA (X), as of Mar 25, the value is 24.66. This value exceeds the healthy maximum of 15. It has decreased from 46.46 (Mar 24) to 24.66, marking a decrease of 21.80.
  • For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 3.63. This value exceeds the healthy maximum of 3. It has decreased from 6.97 (Mar 24) to 3.63, marking a decrease of 3.34.
  • For Retention Ratios (%), as of Mar 25, the value is 56.15. This value is within the healthy range. It has decreased from 68.95 (Mar 24) to 56.15, marking a decrease of 12.80.
  • For Price / BV (X), as of Mar 25, the value is 4.83. This value exceeds the healthy maximum of 3. It has decreased from 10.15 (Mar 24) to 4.83, marking a decrease of 5.32.
  • For Price / Net Operating Revenue (X), as of Mar 25, the value is 3.63. This value exceeds the healthy maximum of 3. It has decreased from 6.97 (Mar 24) to 3.63, marking a decrease of 3.34.
  • For EarningsYield, as of Mar 25, the value is 0.01. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

Fair Value

Fair Value of Relaxo Footwears Ltd as of February 20, 2026 is: ₹307.73

Calculation basis:

  • Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100)
  • P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
  • Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
  • Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
  • Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.

As of February 20, 2026, Relaxo Footwears Ltd is Overvalued by 15.69% compared to the current share price ₹365.00

Intrinsic Value of Relaxo Footwears Ltd as of February 20, 2026 is: ₹290.42

Calculation basis:

  • Intrinsic value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100) * (1 + EPS CAGR for Last 5 Years)
  • P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
  • Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
  • Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
  • Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
  • EPS CAGR (Compound Annual Growth Rate): Represents the geometric mean growth rate of earnings per share over the last 5 years. It provides insight into the historical growth trajectory of the company's earnings.

This formula allows us to gauge the intrinsic value of the stock by analyzing its fundamental indicators along with EPS growth.

As of February 20, 2026, Relaxo Footwears Ltd is Overvalued by 20.43% compared to the current share price ₹365.00

Last 5 Year EPS CAGR: -5.62%

*Investments are subject to market risks

Strength and Weakness

StrengthWeakness
  1. The stock has a high average ROCE of 22.75%, which is a positive sign.
  2. The company has higher reserves (1,233.23 cr) compared to borrowings (182.31 cr), indicating strong financial stability.
  3. The company has shown consistent growth in sales (1.62 cr) and profit (234.23 cr) over the years.
  1. The stock has a high average Working Capital Days of 40.33, which may not be favorable.
  2. The stock has a high average Cash Conversion Cycle of 120.25, which may not be favorable.

Stock Analysis

  • Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Relaxo Footwears Ltd:
    1. Net Profit Margin: 6.1%
      • Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
    2. ROCE: 10.83% (Industry Average ROCE: 11.71%)
      • ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
    3. ROE%: 8.11% (Industry Average ROE: 8.72%)
      • ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
    4. Interest Coverage Ratio (Post Tax): 9.24
      • Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
    5. Quick Ratio: 1.5
      • Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
    6. Stock P/E: 54.2 (Industry average Stock P/E: 45.6)
      • Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
    7. Total Debt / Equity: 0
      • Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
    The current analysis is available for review. It's important to conduct thorough research and consider consulting with financial professionals before making any investment decisions.
    Stock Rating:

About the Company - Qualitative Analysis

Relaxo Footwears Ltd. is a Public Limited Listed company incorporated on 13/09/1984 and has its registered office in the State of Delhi, India. Company's Corporate Identification Number(CIN) is L74899DL1984PLC019097 and registration number is 019097. Currently Company is involved in the business activities of Manufacture of footwear. Company's Total Operating Revenue is Rs. 2789.61 Cr. and Equity Capital is Rs. 24.89 Cr. for the Year ended 31/03/2025.
INDUSTRYADDRESSCONTACT
FootwearsAggarwal City Square, Plot No. 10, Manglam Place, Delhi Delhi 110085Contact not found
Management
NamePosition Held
Mr. Ramesh Kumar DuaChairman & Managing Director
Mr. Mukand Lal DuaWhole Time Director
Mr. Nikhil DuaWhole Time Director
Mr. Gaurav DuaWhole Time Director
Mr. Sushil BatraExecutive Director
Mr. Kuldip Singh DhingraIndependent Director
Mr. Rajeev Rupendra BhadauriaIndependent Director
Ms. Richa AroraIndependent Director
Mr. Yogesh KapurIndependent Director
Mr. Raj Kumar JainIndependent Director

FAQ

What is the intrinsic value of Relaxo Footwears Ltd?

Relaxo Footwears Ltd's intrinsic value (as of 20 February 2026) is ₹290.42 which is 20.43% lower the current market price of ₹365.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹9,095 Cr. market cap, FY2025-2026 high/low of ₹531/351, reserves of ₹2,085 Cr, and liabilities of ₹2,870 Cr.

What is the Market Cap of Relaxo Footwears Ltd?

The Market Cap of Relaxo Footwears Ltd is 9,095 Cr..

What is the current Stock Price of Relaxo Footwears Ltd as on 20 February 2026?

The current stock price of Relaxo Footwears Ltd as on 20 February 2026 is ₹365.

What is the High / Low of Relaxo Footwears Ltd stocks in FY 2025-2026?

In FY 2025-2026, the High / Low of Relaxo Footwears Ltd stocks is ₹531/351.

What is the Stock P/E of Relaxo Footwears Ltd?

The Stock P/E of Relaxo Footwears Ltd is 54.2.

What is the Book Value of Relaxo Footwears Ltd?

The Book Value of Relaxo Footwears Ltd is 84.7.

What is the Dividend Yield of Relaxo Footwears Ltd?

The Dividend Yield of Relaxo Footwears Ltd is 0.83 %.

What is the ROCE of Relaxo Footwears Ltd?

The ROCE of Relaxo Footwears Ltd is 11.2 %.

What is the ROE of Relaxo Footwears Ltd?

The ROE of Relaxo Footwears Ltd is 8.31 %.

What is the Face Value of Relaxo Footwears Ltd?

The Face Value of Relaxo Footwears Ltd is 1.00.

Disclaimer: This article is for informational purposes only and should not be construed as financial advice. The author is not a SEBI registered financial advisor and does not have any vested interest in Relaxo Footwears Ltd. Investors are advised to conduct their own due diligence and consult with a financial professional before making any investment decisions. The information provided in this article is based on publicly available data and the author's analysis, but it may not be comprehensive or up-to-date. The author and getaka.co.in are not responsible for any errors or omissions in the content. This article is not intended to promote any particular investment strategy or recommendation, and readers should consult with their own financial advisors before making any investment decisions. Data Source: NSE
Explore Industry-wise Stock Analysis Reports